Stroke Volume Variation-guided Fluid Infusion in Major Liver Tumour Resection

Sponsor
Kaohsiung Veterans General Hospital. (Other)
Overall Status
Completed
CT.gov ID
NCT05361252
Collaborator
(none)
118
1
2
22.9
5.1

Study Details

Study Description

Brief Summary

Studies have demonstrated that the rate of change in stroke volume variation (SVV) can be used to determine the volume of body fluids during major abdominal surgery. Anaesthesiologists can use SVV as a guide for the appropriate administration of intraoperative fluids to improve postoperative prognoses. Liver surgery is a major abdominal operation, and the amount of blood lost is typically higher than that during other general abdominal surgeries. Blood loss is positively correlated with the intraoperative fluid infusion volume, and greater blood loss is associated with more postoperative complications. Additionally, comorbid liver disease or cirrhosis can increase the complexity of liver tumour resection, causing difficulty in assessing intravascular volume and determining the appropriate intraoperative infusion volume.

Condition or Disease Intervention/Treatment Phase
  • Procedure: SVV-guided fluid management
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
118 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This trial had a randomised study design with simple randomisation and a fixed allocation ratio (1:1 to the low-SVV group or high-SVV group). The patients were blinded to the randomisation and allocation.This trial had a randomised study design with simple randomisation and a fixed allocation ratio (1:1 to the low-SVV group or high-SVV group). The patients were blinded to the randomisation and allocation.
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Restrictive Versus Liberal Stroke Volume Variation-guided Fluid Infusion in Major Liver Tumour Resection: a Prospective Randomised Trial of Perioperative Quality of Care
Actual Study Start Date :
Feb 1, 2017
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: the low-SVV group

the value of stroke volume variation will be less than or equal to 10 this group

Procedure: SVV-guided fluid management
fluid will be guided by value of stroke volume variation

Active Comparator: the high-SVV group

the value of stroke volume variation will be higher than 10 this group

Procedure: SVV-guided fluid management
fluid will be guided by value of stroke volume variation

Outcome Measures

Primary Outcome Measures

  1. The incidence of postoperative complications in the two groups. [From day 1 to day 30 after surgery.]

    calculate the incidence of postoperative complication within 30 days

Secondary Outcome Measures

  1. The differences of perioperative ALT [Examination report on the 1st postoperative day.]

    Calculate the difference of the perioperative physiological variables

  2. The differences of perioperative eGFR [Examination report on the 1st postoperative day.]

    Calculate the difference of the perioperative physiological variables

  3. The differences of perioperative creatinine [Examination report on the 1st postoperative day.]

    Calculate the difference of the perioperative physiological variables

  4. The differences of perioperative T.bil [Examination report on the 1st postoperative day.]

    Calculate the difference of the perioperative physiological variables

  5. The differences of perioperative Hb [Examination report on the 1st postoperative day.]

    Calculate the difference of the perioperative physiological variables

  6. The differences of perioperative arterial lactate [Examination report on the 1st postoperative day.]

    Calculate the difference of the perioperative physiological variables

  7. The differences of perioperative albumin [Examination report on the 1st postoperative day.]

    Calculate the difference of the perioperative physiological variables

  8. The pain scale [up to three days postoperatively]

    Assessment of postoperative pain scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • We initially selected 118 patients who required hepatectomy.

  • The physiological status of the patients was assessed in terms of American Society of Anesthesiologists scores I-III

Exclusion Criteria:
  • Extreme body mass index (BMI)

  • Age under 20 or over 75 years

  • Emergency surgery

  • Preexisting cardiac, hepatic, renal, or coagulation disorder; hyperthyroidism; and sinus arrhythmia.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaohsiung Veterans General Hospital Kaohsiung Taiwan 81362

Sponsors and Collaborators

  • Kaohsiung Veterans General Hospital.

Investigators

  • Principal Investigator: Yuan-Yi Chia, Director, Kaohsiung Veterans General Hospital.
  • Study Director: Kai-Wei Hsieh, physician, Kaohsiung Veterans General Hospital.
  • Study Chair: We-Yu Chen, physician, Kaohsiung Veterans General Hospital.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yuan-Yi Chia, Chief of Anesthesiology, Kaohsiung Veterans General Hospital.
ClinicalTrials.gov Identifier:
NCT05361252
Other Study ID Numbers:
  • VGHKS16-CT8-25
First Posted:
May 4, 2022
Last Update Posted:
Jul 1, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yuan-Yi Chia, Chief of Anesthesiology, Kaohsiung Veterans General Hospital.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 1, 2022